Shiran Zimri

Shiran Zimri

Company: NeuroSense Therapeutics

Job title: Vice President of Research and Development


Exploring the Potentials of Combination Therapy in ALS & Showcasing Latest Progress of PrimeC 11:30 am

Evaluating the promise that combination treatment holds, with recent examples from PrimeC studies Highlighting the benefits of a combination approach to treat ALS  Outlining the developmental plan with considerations of MoA for early clinical studiesRead more

day: Day One Track B AM

Navigating the Hurdles of a Combination Therapy Approach & the Need to Demonstrate Efficacy on Top of Existing ALS Treatments 11:05 am

In a world where numerous ALS drugs begin to exist, new challenges of trial enrolment, patient availability and an evolving standard of care emerge. Engage in forward-thinking discussions around the future of ALS drug development as increasing numbers of therapies reach the clinic: How can we overcome anticipated trial complications due to varying standards of…Read more

day: Pre-Conference Day

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.